Concordance Between Cerebrospinal Fluid Biomarkers with Alzheimer's Disease Pathology Between Three Independent Assay Platforms
James D Doecke, Alan Rembach, Victor L Villemagne, Shiji Varghese, Stephanie Rainey-Smith, Shannon Sarros, Lisbeth A Evered, Christopher J Fowler, Kelly K Pertile, Rebecca L Rumble, Brett Trounson, Kevin Taddei, Simon M Laws, S Lance Macaulay, Ashley I Bush, Kathryn A Ellis, Ralph Martins, David Ames, Brendan Silbert, Hugo Vanderstichele Show all
JOURNAL OF ALZHEIMERS DISEASE | IOS PRESS | Published : 2018
Awarded by NHMRC
The Florey Institute of Neuroscience and Mental Health acknowledges funding support from the Victorian government's Operational Infrastructure Support program. Alzheimer's Australia (Victoria and Western Australia) assisted with promotion of the study. SC is supported in part by a NHMRC Practitioner Fellowship (#APP1105784). VLV is supported in part by a NHMRC Research Fellowship (#APP1046471). This study would like to acknowledge the generous participation of the AIBL participants, who kindly provided their time and resources so that this research was possible.Core funding for the study was provided by the Science and Industry Endowment Fund (http://www.sief.org.au) and CSIRO, which was supplemented by in kind contributions from the study partners (see http://www.aibl.csiro.au). The research was also supported by the National Health and Medical Research Council (NHMRC) via the Dementia Collaborative Research Centres program (DCRC).